Lexaria Bioscience

Quarterly Financials

Values in thousands 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Revenue
$174
$174
$183
$84
Gross Profit
174
174
181
84
EBITDA
-3,750
-2,751
-2,690
-2,201
EBIT
-2,753
-2,723
-2,218
Net Income
-3,789
-2,713
-2,703
-2,184
Net Change In Cash
174
174
183
84
Free Cash Flow
-3,583
-1,497
-2,726
-1,961
Cash
4,591
6,468
8,078
6,499
Basic Shares
18,298
17,511
16,668
13,119

Annual Financials

Values in thousands 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Revenue
$464
$226
$255
$722
Gross Profit
459
194
183
547
EBITDA
-5,676
-6,388
-6,516
-5,539
EBIT
-5,753
-6,534
-6,619
-5,686
Net Income
-5,795
-6,664
-7,269
-4,027
Net Change In Cash
464
226
255
722
Free Cash Flow
-5,002
-6,050
-5,010
-4,069
Cash
6,499
1,352
5,813
10,917
Basic Shares
12,383
6,614
5,885
4,391